[1]
S. Schreier, P. Budchart, S. Borwornpinyo, W. Arpornwirat, and W. Triampo, “Circulating erythroblast abnormality associated with systemic pathologies may indicate bone marrow damage”, J Circ Biomark, vol. 10, no. 1, pp. 14–19, Aug. 2021.